PsyBio Therapeutics Corp.
-
Head Office:
1624 Washington St., Denver, CO 80203 USA -
Reporting Since:
2010-11-09
Previous Names:
Leo Acquisitions Corp.
Issuer Status:
Cease Traded as of 2023-12-05
In Default as of 2023-11-30
Year End:
December 31Principal Regulator:
British ColumbiaDefault History
Period of Default | Default Code | Default From | Default To |
---|---|---|---|
Q3 2023-09-30
|
1b.,1c.,1e.,3
|
2023-11-30
|
|
Q2 2023-06-30
|
1b.,1c.,1e.,3
|
2023-08-30
|
2023-08-31
|
Q2 2019-12-31
|
1b.,1c.,1e.,3
|
2020-03-05
|
2020-05-04
|
Q3 2018-03-31
|
1b.,1c.,1e.,3
|
2018-06-04
|
2018-06-07
|
Q1 2017-09-30
|
1b.,1c.,1e.,3
|
2017-12-01
|
2017-12-04
|
Q2 2014-12-31
|
1b.,1c.,1e.,3
|
2015-03-03
|
2015-03-06
|
Q3 2013-03-31
|
1b.,1c.,1e.,3
|
2013-06-03
|
2013-06-11
|
Q2 2010-12-31
|
1b.,1c.,1e.,3
|
2011-03-02
|
2011-03-03
|
Historical Exempt Distributions
Exempt Distribution filings made after 25-July-2023 can be viewed in SEDAR+
Exemption | Document Type | Distribution From | Distribution To | $ Amount Raised | Filing Date |
---|---|---|---|---|---|
NI 45-106 2.3
|
2023-01-04
|
2023-01-13
|
909987.0000
|
2023-01-13
|
|
NI 45-106 2.3
|
2016-10-21
|
2016-10-21
|
36363.6000
|
2016-10-31
|
Exemption Orders
Nothing on File